玻璃体内注射贝伐单抗治疗放射性黄斑病变。

Radiation maculopathy treated with intravitreal bevacizumab.

作者信息

Sánchez-Vicente J L, Muñoz-Morales A, Galván-Carrasco M P, Castilla-Lázpita A, Vital-Berral C, Alfaro-Juárez A, Rueda-Rueda T

机构信息

Unidad de Gestión Clínica de Oftalmología, Hospital Universitario Virgen del Rocío, Sevilla, España.

出版信息

Arch Soc Esp Oftalmol. 2017 Jun;92(6):283-286. doi: 10.1016/j.oftal.2016.10.008. Epub 2016 Nov 25.

DOI:10.1016/j.oftal.2016.10.008

PMID:27894518

Abstract

CASE REPORT

A 47 year-old woman with a choroidal melanoma developed a macular oedema secondary to radiation therapy 75 months after brachytherapy plaque. The patient received 3 intravitreal Bevacizumab injections.

DISCUSSION

The patient had a good response to bevacizumab treatment. In fact, there was a reduction in the macular oedema measured by optical coherence tomography (OCT) scan, as well as an improvement in best corrected visual acuity. There was no recurrence of macular oedema, and visual acuity remained stable after 3-years follow-up.

摘要